Millennium Management’s Aegerion Pharmaceuticals AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-165,879
| Closed | -$493K | – | 4014 |
|
|
2016
Q3 | $493K | Sell |
165,879
-75,711
| -31% | -$131K | ﹤0.01% | 2611 |
|
|
2016
Q2 | $360K | Sell |
241,590
-338,045
| -58% | -$773K | ﹤0.01% | 2651 |
|
|
2016
Q1 | $2.15M | Sell |
579,635
-963,727
| -62% | -$5.97M | 0.01% | 1733 |
|
|
2015
Q4 | $15.6M | Buy |
1,543,362
+134,966
| +10% | +$1.62M | 0.03% | 675 |
|
|
2015
Q3 | $19.2M | Sell |
1,408,396
-94,047
| -6% | -$1.67M | 0.04% | 586 |
|
|
2015
Q2 | $28.5M | Buy |
1,502,443
+406,206
| +37% | +$8.79M | 0.05% | 458 |
|
|
2015
Q1 | $28.7M | Sell |
1,096,237
-431,620
| -28% | -$11M | 0.05% | 477 |
|
|
2014
Q4 | $32M | Buy |
1,527,857
+1,329,099
| +669% | +$33.5M | 0.07% | 388 |
|
|
2014
Q3 | $6.63M | Sell |
198,758
-114,134
| -36% | -$3.54M | 0.02% | 1107 |
|
|
2014
Q2 | $10M | Buy |
312,892
+101,295
| +48% | +$3.77M | 0.03% | 818 |
|
|
2014
Q1 | $9.77M | Buy |
211,597
+145,791
| +222% | +$8.55M | 0.03% | 820 |
|
|
2013
Q4 | $4.67M | Sell |
65,806
-107,009
| -62% | -$8.18M | 0.01% | 1228 |
|
|
2013
Q3 | $14.8M | Sell |
172,815
-141,327
| -45% | -$12M | 0.05% | 502 |
|
|
2013
Q2 | $19.9M | Buy |
+314,142
| New | +$16.7M | 0.06% | 320 |
|
Millennium Management's AEGR Position: Q4 2016 in Review
Millennium Management sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 165,879 shares — an estimated $493K sold.
Millennium Management first reported a position in AEGR in Q2 2013 and held it in 14 quarters. The position peaked at $32M in Q4 2014. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.
- Millennium Management reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
- Millennium Management sold 165,879 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $493K.
- Millennium Management first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 14 quarters.
- Millennium Management's Aegerion Pharmaceuticals position peaked at $32M in Q4 2014.
- 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.